Literature DB >> 28871004

miR18a and miR19a Recruit Specific Proteins for Splicing in Thyroid Cancer Cells.

Marcelo M Paiva1, Edna T Kimura1, Patricia P Coltri2.   

Abstract

BACKGROUND: Thyroid cancer is one of the most frequent types of endocrine cancers. In most cases, thyroid cancers are caused by deregulated miRNA expression, especially involving the miR17-92 cluster. miR17-92 transcription is altered in several different tumor types including lymphoma, leukemia, and of the breast and thyroid. As an intronic cluster, miR17-92 must be processed during splicing and therefore interaction between microprocessor and spliceosome machineries is of major importance in understanding its expression.
MATERIALS AND METHODS: We investigated the protein composition of spliceosomes assembled on pre-RNAs containing intronic miR18a and miR19a, components of the miR17-92 cluster, using mass spectrometry.
RESULTS: Interestingly, we observed that proteins associated with intronic miR18a and miR19a are cell-specific, and are similar for both miRNAs analyzed. The only exception is the group of heterogeneous nuclear proteins that are commonly recruited by different cells.
CONCLUSION: miRNA processing depends on cell-specific proteins and heterogeneous nuclear proteins have a general role in miRNA processing from introns. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Splicing; miR17-92 cluster; miRNA; thyroid cancer

Mesh:

Substances:

Year:  2017        PMID: 28871004      PMCID: PMC5611523          DOI: 10.21873/cgp.20047

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  31 in total

1.  High iodine blocks a Notch/miR-19 loop activated by the BRAF(V600E) oncoprotein and restores the response to TGFβ in thyroid follicular cells.

Authors:  Cesar Seigi Fuziwara; Edna Teruko Kimura
Journal:  Thyroid       Date:  2014-01-29       Impact factor: 6.568

2.  The role of microRNA genes in papillary thyroid carcinoma.

Authors:  Huiling He; Krystian Jazdzewski; Wei Li; Sandya Liyanarachchi; Rebecca Nagy; Stefano Volinia; George A Calin; Chang-Gong Liu; Kaarle Franssila; Saul Suster; Richard T Kloos; Carlo M Croce; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

3.  Functional Anatomy of the Human Microprocessor.

Authors:  Tuan Anh Nguyen; Myung Hyun Jo; Yeon-Gil Choi; Joha Park; S Chul Kwon; Sungchul Hohng; V Narry Kim; Jae-Sung Woo
Journal:  Cell       Date:  2015-05-28       Impact factor: 41.582

4.  c-Myc-regulated microRNAs modulate E2F1 expression.

Authors:  Kathryn A O'Donnell; Erik A Wentzel; Karen I Zeller; Chi V Dang; Joshua T Mendell
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

5.  A microRNA polycistron as a potential human oncogene.

Authors:  Lin He; J Michael Thomson; Michael T Hemann; Eva Hernando-Monge; David Mu; Summer Goodson; Scott Powers; Carlos Cordon-Cardo; Scott W Lowe; Gregory J Hannon; Scott M Hammond
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

6.  TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes.

Authors:  Yukio Kawahara; Ai Mieda-Sato
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-09       Impact factor: 11.205

7.  Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas.

Authors:  Ping Mu; Yoon-Chi Han; Doron Betel; Evelyn Yao; Massimo Squatrito; Paul Ogrodowski; Elisa de Stanchina; Aleco D'Andrea; Chris Sander; Andrea Ventura
Journal:  Genes Dev       Date:  2009-12-15       Impact factor: 11.361

8.  Differential connectivity of splicing activators and repressors to the human spliceosome.

Authors:  Martin Akerman; Oliver I Fregoso; Shipra Das; Cristian Ruse; Mads A Jensen; Darryl J Pappin; Michael Q Zhang; Adrian R Krainer
Journal:  Genome Biol       Date:  2015-06-06       Impact factor: 13.583

9.  A microRNA expression signature of human solid tumors defines cancer gene targets.

Authors:  Stefano Volinia; George A Calin; Chang-Gong Liu; Stefan Ambs; Amelia Cimmino; Fabio Petrocca; Rosa Visone; Marilena Iorio; Claudia Roldo; Manuela Ferracin; Robyn L Prueitt; Nozumu Yanaihara; Giovanni Lanza; Aldo Scarpa; Andrea Vecchione; Massimo Negrini; Curtis C Harris; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-03       Impact factor: 11.205

10.  miR-17-92 fine-tunes MYC expression and function to ensure optimal B cell lymphoma growth.

Authors:  Marija Mihailovich; Michael Bremang; Valeria Spadotto; Daniele Musiani; Elena Vitale; Gabriele Varano; Federico Zambelli; Francesco M Mancuso; David A Cairns; Giulio Pavesi; Stefano Casola; Tiziana Bonaldi
Journal:  Nat Commun       Date:  2015-11-10       Impact factor: 14.919

View more
  3 in total

1.  hnRNP A1 and hnRNP C associate with miR-17 and miR-18 in thyroid cancer cells.

Authors:  Maria Gabriela Pereira Dos Santos; Guilherme Henrique Gatti da Silva; Helder Yudi Nagasse; Cesar Seigi Fuziwara; Edna T Kimura; Patricia Pereira Coltri
Journal:  FEBS Open Bio       Date:  2022-04-24       Impact factor: 2.792

2.  Downregulation of miR‑486‑5p in papillary thyroid carcinoma tissue: A study based on microarray and miRNA sequencing.

Authors:  Dong-Yue Wen; Deng-Hua Pan; Peng Lin; Qiu-Yan Mo; Yun-Peng Wei; Yi-Huan Luo; Gang Chen; Yun He; Jun-Qiang Chen; Hong Yang
Journal:  Mol Med Rep       Date:  2018-07-03       Impact factor: 2.952

3.  Interaction paths promote module integration and network-level robustness of spliceosome to cascading effects.

Authors:  Paulo R Guimarães; Mathias M Pires; Maurício Cantor; Patricia P Coltri
Journal:  Sci Rep       Date:  2018-11-28       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.